Rocket pharmaceuticals, inc. (RCKT)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Operating Activities:
Net loss

-77,270

-74,518

-19,578

-42,854

-67,982

Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on convertible notes

3,602

3,059

0

-

-

Amount of reduction in lease liability.

0

161

0

-

-

Series A preferred shares issued for services

-

-

0

-

-

Depreciation expense

426

330

204

169

45

Change in fair value of warrant liabilities

-

-

-

-

-267

Change in fair value of Convertible Bridge Notes redemption rights derivative

-

-

-

-

-480

Change in fair value of 2020 Convertible Notes derivative liability

-

-

-

-

-42,793

Stock-based compensation

13,371

13,601

1,320

2,909

2,380

Loss on extinguishment of debt

-

-

-

-

-4,239

Amortization of premium on short term investments

-

-

-

225

75

Noncash interest expense

-

-

-

222

1,132

Amount of rent expense or loss included in net income that result in non cash flow.

-

-

0

60

20

Loss on disposal of property and equipment

0

-317

0

-

-

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.

1,066

801

-

-

-

Accretion of discount on investments

-

-

0

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

917

1,505

720

948

1,256

Accounts payable and accrued expenses

-2,722

5,890

2,812

-

-

Amount of increase (decrease) in present value of lessee's discounted obligation for lease payments from operating lease.

-87

0

-

-

-

Accounts payable

-

-

-

-41

487

Accrued expenses and other liabilities

-

-

-

3,112

1,438

Net cash used in operating activities

-64,663

-53,788

-15,962

-37,266

-17,416

Investing activities:
Cash acquired in connection with the Reverse Merger

0

76,348

0

-

-

Purchases of investments

184,298

141,087

0

-

-

Purchases of short-term investments

-

-

-

122,277

33,693

Proceeds from maturities of investments

168,556

61,276

0

56,705

2,430

Proceeds from sale of property and equipment

0

20

0

-

-

Purchases of property and equipment

23,269

1,453

760

-

-

The cash outflow associated with the purchase of security deposits.

0

376

0

-

-

Net cash provided by investing activities

-39,011

-5,272

-760

-66,059

-31,675

Financing activities:
Proceeds from sale of treasury stock

344

0

-

-

-

Payments from related party payable

-

-

0

-

-

Common stock repurchase

0

668

0

-

-

Net proceeds from issuance of common stock in initial public offering

-

-

-

-

38,085

Proceeds from issuance of 2020 Convertible Notes in initial public offering

-

-

-

-

21,000

Net proceeds from issuance of common stock

-

-

-

3,997

73,965

Gross proceeds, offering amount

177,760

154,022

0

-

-

Issuance of common stock, pursuant to exercise of stock options

31

148

0

-

-

Purchase of property and equipment

-

-

-

487

412

Payment of witholding tax on option exercise

344

0

-

-

-

Principal payments on notes payable

-

-

-

-

5,800

Net cash used in financing activities

177,791

153,502

25,406

53,081

125,515

Net change in cash, cash equivalents and restricted cash

74,117

94,442

8,684

-50,244

76,424

Supplemental disclosure of non-cash financing and investing activities:
Accrued purchases of property and equipment

4,424

0

-

-

-

Accrued purchases of internal use software

226

0

-

-

-

The value of treasury stock purchases paid in prior year classified as noncash financing activities.

726

0

-

-

-

The fair value of retired treasury stock in noncash investing and financing activities.

1,393

0

-

-

-

Amount of withholding tax payable on shares withheld in treasury stock classified as noncash financing activities.

53

0

-

-

-

Acquisition of leasehold improvements

-

-

-

-

445

Conversion of convertible preferred stock into common stock

0

41,466

0

-

-

Unrealized (loss) gain on investments

147

-127

0

-43

-11

Supplemental cash flow information:
Cash paid for interest

2,990

4,485

0

-

89

Cash paid for income taxes

26

2

0

-

-

Conversion of Notes into common stock

-

-

-

-

66,376

Stock Option Plans [Member]
Proceeds from the issuance of common stock

-

-

-

191

-

Employee Stock Purchase Plan [Member]
Proceeds from the issuance of common stock

-

-

-

155

-

Series A preferred stock that may be exchanged into common shares or other types of securities at the owner's option.
Proceeds from issuance of convertible preferred stock, net

-

-

0

-

-

Series B preferred stock that may be exchanged into common shares or other types of securities at the owner's option.
Proceeds from issuance of convertible preferred stock, net

-

-

25,406

-

-

2021 Convertible Notes [Member]
Proceeds from issuance of 2021 Convertible Notes

-

-

-

52,000

-

Payments of 2021 Convertible Notes issuance costs

-

-

-

3,262

-